Search
-
La part moyenne de la population LGBT+ dans le monde s'élève à 9%
Dans les 30 pays où l’enquête a été menée, le soutien à la protection des personnes transgenres contre les discriminations en matière d’emploi et de logement est très élevé, mais les avis sur d’autres mesures sont plus mitigés
-
A guide to better pharma demand research
Discover the three essential steps for optimizing the quality and reliability of demand research.
-
Ipsos Update – May 2023
Generations, corporate purpose, climate change… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos teams around the world.
-
Ipsos Webinar : Digital strategy as a key driver of success in healthcare
Maximizing the impact of Digital Customer Engagement Strategies has become more and more prominent within the healthcare sector.
-
What patients and practicians say about the pains of Eczema
Today is World Atopic Eczema Day, established to enhance awareness, understanding and management of a skin condition that can severely affect patients’ health and wellbeing.
-
Oncology in the Time of COVID
The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.
-
Conquering Complexity: The ongoing revolution in oncology biomarker testing
The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalised medicine now well-entrenched in the treatment paradigm.
-
The rise of self-care - how the empowered patient & consumer will drive the future of health [Webinar Recording]
Please join us for the webinar
-
Impact of the Covid-19 pandemic on health
How COVID-19 has changed the overall health of people? In what areas did their health decline or remain stable? To what extent did people experience new health problems or worsen pre-existing conditions? What proportion of individuals gave up treatment or care during the pandemic? For what reasons? Was this absence of treatments or visits compensated by a greater use of telemedicine and digital applications?